Investigation Overview
September 12, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cynapsus Therapeutics Inc (NASDAQ:CYNA), was announced concerning whether the takeover of Cynapsus Therapeutics Inc by Sunovion Pharmaceuticals Inc for $40.50 per share is unfair to NASDAQ:CYNA stockholders. The investigation by a law firm concerns whether certain offi...
You must register (for free) or login to view the entire investigation.